Lucan · Conditions

Term prelabour rupture of membranes

Australian guidance: RANZCOG C-Obs 36 Term PROM (2021)

1. Definition and epidemiology

Term prelabour rupture of membranes (term PROM) is defined as rupture of the foetal membranes prior to the onset of labour at or beyond 37 weeks gestation. The incidence in Australia is approximately 8% of all pregnancies at term. The majority of women (70%) will commence labour spontaneously within 24 hours of rupture, and 85% within 48 hours; 95% will labour spontaneously within 96 hours if managed expectantly.

2. Pathophysiology

The foetal membranes are a bilayer structure comprising the inner amnion and outer chorion, held together by collagen and proteoglycans. Normal membrane integrity depends on a balance between collagen synthesis and matrix metalloproteinase (MMP) mediated degradation. In term PROM, this balance is disrupted by several converging mechanisms. Physiological cervical ripening near term activates MMPs and prostaglandins that weaken the lower pole of the membranes. Subclinical chorioamnionitis, driven by ascending bacterial colonisation, accelerates MMP activity and releases inflammatory cytokines (particularly interleukin-1 and tumour necrosis factor alpha) that further degrade the extracellular matrix. Mechanical shear stress at the internal os, especially with polyhydramnios, foetal macrosomia, or multiple pregnancy, adds a physical dimension to the biochemical weakening. Oxidative stress from smoking and nutritional deficiencies in ascorbic acid (a cofactor in collagen cross-linking) are additional contributors. The result is focal membrane thinning at the zone of altered morphology overlying the cervical os, leading to spontaneous rupture. Once the barrier is breached, ascending infection risk rises with time, making the latency interval from rupture to delivery a central concern in management.

3. Clinical presentation and diagnostic criteria

The classic presentation is a sudden gush of clear or pale yellow fluid from the vagina, often followed by a persistent or intermittent trickle. The woman may report difficulty distinguishing fluid loss from urinary incontinence or increased vaginal discharge. On history, the clinician confirms gestational age, confirms cephalic presentation, assesses foetal movements, and screens for signs of infection including maternal fever, rigors, and uterine tenderness. Sterile speculum examination is the cornerstone of diagnosis and allows direct visualisation of amniotic fluid pooling in the posterior fornix. Digital vaginal examination should be avoided unless immediate induction is planned, as it increases neonatal infection rates. Cardiotocography (CTG) assesses foetal wellbeing and identifies cord compression patterns. Liquor colour is noted; green or brown discolouration suggests meconium and warrants expedited management. The combination of history, speculum findings, and CTG establishes the diagnosis in the great majority of cases.

4. Investigations and AU-specific cutoffs

First-line investigations are clinical and should be completed promptly on presentation:

1. Sterile speculum examination: visualisation of fluid in the posterior fornix confirms diagnosis. If equivocal, proceed to biochemical testing.
2. Amnisure (placental alpha microglobulin-1 immunoassay) or similar amniotic fluid protein test: indicated only when clinical diagnosis remains uncertain after speculum. The RANZCOG C-Obs 36 guidance cautions that false positive rates of 19 to 30% have been reported in women with clinically intact membranes who have symptoms of labour, and that the US FDA has issued a warning against over-reliance on these tests. False positives also occur in the presence of blood, semen, alkaline antiseptics, trichomonas, or bacterial vaginosis. pH testing (Nitrazine paper) is less reliable and is not the preferred method.
3. CTG: performed on all women at initial assessment to confirm foetal wellbeing and exclude cord prolapse or compression.
4. Group B streptococcus (GBS) status: review antenatal swab result (taken at 35 to 37 weeks). If unknown, treat as positive pending result or manage per local protocol.
5. Maternal observations: temperature, pulse, blood pressure, and uterine tenderness as baseline infection screen.
6. Full blood count and C-reactive protein if clinical signs of chorioamnionitis are present.

There are no AU-specific numerical cutoffs for latency management beyond the 24-hour induction threshold endorsed at Grade A evidence level.

5. Management

Management hinges on a shared decision between the woman, her partner, and the clinical team, weighing the benefits of active management against individual preferences for expectant management.

Active management (recommended): Induction of labour within 24 hours is recommended for all women at term where it is practical (Grade A, RANZCOG C-Obs 36). A large Cochrane meta-analysis and the TermPROM trial demonstrated that planned early birth compared with expectant management reduces maternal chorioamnionitis (RR 0.49; 95% CI 0.33 to 0.72), reduces early-onset neonatal sepsis (RR 0.73; 95% CI 0.58 to 0.92), reduces neonatal antibiotic use (RR 0.61; 95% CI 0.44 to 0.84), and reduces neonatal special care unit admissions (RR 0.75; 95% CI 0.66 to 0.85), without increasing the caesarean section rate (RR 0.84; 95% CI 0.69 to 1.04). Women in the active management group also reported greater satisfaction.

For women known to carry vaginal GBS or being treated as GBS positive, induction should commence as soon as practicable after confirmed rupture, together with prophylactic intrapartum antibiotics per the RANZCOG C-Obs 19 GBS guideline (Grade A). Timing of caesarean section in GBS-positive women depends on local service capability.

Expectant management (if chosen): Suitable candidates have a fixed cephalic presentation, confirmed GBS-negative status with no prior history of early-onset GBS (EOGBS) disease in a neonate, no clinical signs of infection, a normal CTG, clear amniotic fluid, and access to reliable transport. Monitoring consists of four-hourly maternal temperature, vaginal loss assessment, and foetal movement checks during waking hours. A post hoc analysis of the TermPROM trial found that expectant management at home was associated with increased neonatal infection compared with expectant management in hospital (OR 1.97; 95% CI 1.00 to 3.90), so in-hospital monitoring is preferred.

Chorioamnionitis: When chorioamnionitis is diagnosed or clinically suspected, delivery should be expedited and broad-spectrum intravenous antibiotics commenced without delay.

6. Pharmacology and AU PBS notes

Induction agents:

Intravenous oxytocin is the standard first-line agent for induction of labour in Australia in women with term PROM. Syntocinon (oxytocin, Pfizer Australia) is the AU brand; it is administered by controlled intravenous infusion titrated to achieve adequate uterine contractions. No PBS restriction applies as it is used in an inpatient hospital setting.

For women with an unfavourable cervix (low Bishop score), vaginal prostaglandins may be used instead of or prior to oxytocin (Grade B, RANZCOG C-Obs 36). Options include dinoprostone (Prostin E2, Pfizer; or Cervidil pessary) applied vaginally. Misoprostol (oral, low-dose) has been evaluated in the TermPROM trial and has equivalent outcomes to oxytocin, and is also used in New Zealand practice, though oxytocin remains the usual method in Australian units. Mechanical methods such as balloon catheters are associated with increased infection risk in the PROM context and should generally be avoided.

Antibiotic prophylaxis:

Routine prophylactic antibiotics are not indicated for GBS-negative women where timely induction within 24 hours is planned (Grade A, RANZCOG C-Obs 36). For GBS-positive or GBS-unknown women, benzylpenicillin (penicillin G) intravenously is the first-line agent per RANZCOG C-Obs 19; clindamycin is the alternative for penicillin allergy with low anaphylaxis risk, and vancomycin for high-risk penicillin allergy. These are hospital-administered agents, so PBS status is not applicable.

7. Complications and monitoring

Immediate complications at rupture: Cord prolapse is an obstetric emergency requiring urgent delivery. Cord compression from oligohydramnios may produce variable decelerations on CTG. Placental abruption, though uncommon, can complicate membrane rupture and presents with pain and foetal distress.

Infection complications: Chorioamnionitis develops in a minority but the risk escalates with latency. Clinical features are maternal fever (temperature at or above 38.0 degrees Celsius), maternal tachycardia, foetal tachycardia, uterine tenderness, and offensive vaginal discharge. Neonatal sepsis, including early-onset GBS disease, remains the most serious delayed complication. Chorioamnionitis is independently associated with neonatal cerebral palsy.

Surveillance schedule: Women undergoing active management should have continuous CTG monitoring once oxytocin is commenced and throughout active labour. Women undergoing expectant management require four-hourly maternal observations and foetal movement checks as outlined above, with daily CTG at a minimum and low threshold for escalation to induction if signs of infection or foetal compromise emerge. After birth, neonates born following prolonged rupture (greater than 18 hours) should be observed closely for signs of early-onset sepsis per the Newborn Early Warning Tool and local neonatology protocols.

Written for Australian practice and grounded in the guidance named above. Study material only — not medical advice. Always check against current guidelines.